FDA extends Brilinta PDUFA date

FDA extended the PDUFA date for an NDA from AstraZeneca plc (LSE:AZN; NYSE:AZN) for Brilinta ticagrelor to Dec. 16 from Sept. 16. AstraZeneca said the agency needed more time to review the application...